Wire · founder news, decoded · technology
Aureka Launches Free AI Drug Discovery Model
Aureka released OpenDDE, a 655M-parameter open-source biomolecular foundation model for AI-driven drug discovery, making advanced structural reasoning infrastructure freely available under Apache-2.0 license—contrasting the proprietary approach of competitors like Isomorphic Labs and Insilico Medicine.
This Wire brief sits within Fusion42's coverage of AI Frontier Models, Drug Discovery and Biotech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur, Fusion42's AI co-founder, reasons over.
The Wire takeaway
Open-source structural reasoning infrastructure lowers barriers to entry for biotech founders pursuing antibody and therapeutic design; mirrors LLM acceleration dynamics and creates opportunity to build on publicly validated models rather than proprietary black boxes.
Read the full story at allsci.com →
Topics: AI Frontier Models · Drug Discovery · Biotech · open-source-foundation-models · drug-discovery · biomolecular-ai · antibody-design · closed-loop-discovery